Global Circulating Tumor Cell (CTC) Diagnostics Technologies and Markets Report 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The scope of this study is clinical testing, prognostic and monitoring markets for CTCs in cancer. The report also includes the clinical research segment, currently approved CTC tests and their markets. The regulatory environment, current technologies, new technologies, cancer incidence, market projections and market share along with the latest trends and new developments in this area are included to support the clinical testing market.

The research segment of the market includes numerous competitors with different capabilities, developing and commercializing products such as CTC isolation devices and protocols, CTC characterization reagents, assay and instrumentation, and various identification technologies based on cell imaging. These market players include specialized or research-based companies that contribute considerably to the technological advancements in the field of CTC technologies.

The data collected for the report is focused on breast, prostate and colorectal cancers for which clinical data and tests are available currently on the market. CTCs in other cancers are being researched and some are in clinical trials; these are not included within the scope of this report.

Report Includes:

  • An overview of the global market for cancer diagnostics, based on circulating tumor cells, which are used to increase understanding of tumor cell biology and metastatic cancer as a disease.
  • Analyses of global market trends, with data from 2016, estimates from 2017, and projections of compound annual growth rates (CAGRs) through 2022.
  • Discussions covering the advantages and disadvantages of CTC enrichment techniques.
  • Estimations of cancer incidence, cancer deaths, new cases by type in the United States, and breast cancer statistics and facts.
  • Examination of growth opportunities and drivers in the CTC market and recent breakthroughs in research, along with a patent analysis.
  • Information about the clinical testing, prognostic, and monitoring markets for CTCs in cancer.
  • Coverage of approved CTC tests and their markets, and the regulatory environment.
  • Company profiles of major players across various product categories, including Cytotrack, Menarini-Silicon Biosystems And A. Menarini Diagnostics (Veridex Llc), Greiner Bio-One Gmbh, Cynvenio Biosystems Inc., Biofluidica Microtechnologies Llc and Advanced Cell Diagnostics

Key Topics Covered:

1 Introduction

2 Summary and Highlights

3 Overview and Market Influencers

4 Acetic Acid

5 Formic Acid

6 Propionic Acid

7 Butyric Acid

8 Citric Acid

9 Stearic Acid

10 Valeric Acid

11 Caproic Acid

12 Benzoic Acid

13 Malic Acid

14 Lactic Acid

15 Competitive Landscape

16 Company Profiles

Companies Mentioned

  • Adnagen
  • Advanced Cell Diagnostics
  • Apocell
  • Aviva Biosciences
  • Biocep Ltd.
  • Biocept Inc.
  • Biofluidica Microtechnologies Llc
  • Canopus Biosciences
  • Cellmax Life
  • Celltrafix Inc.
  • Celula
  • Clearbridge Biomedics
  • Creatv Microtech Inc
  • Cynvenio Biosystems Inc.
  • Cytotrack
  • Epic Biosciences
  • Fluxion Biosciences
  • Greiner Bio-One Gmbh
  • Ikonisys Inc.
  • Ivdiagnostics Inc
  • Janssen Diagnostics
  • Menarini-Silicon Biosystems
  • Miltenyi Biotec
  • Nanostring Technologies Inc.
  • Natural Nano Inc.
  • Rarecells
  • Screencell
  • Stemcell Technologies
  • Synergex Corp.
  • Sysmex Corp.
  • Vitatex Inc.

For more information about this report visit https://www.researchandmarkets.com/research/npzhtf/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Oncology Drugs